For the first time, we organized Neuropathy Advocacy Day and took our message directly to Congress. On March 18, 2025, staff and board members from the Foundation traveled to Washington, D.C. to speak up for the 30 million Americans who have peripheral neuropathy (PN). Our visit was urgent because earlier this month, Congress passed a […]
The Foundation for Peripheral Neuropathy (FPN) welcomes Amanda Peltier, MD, MS, to our board of directors, effective Jan. 1, 2025. Her distinguished career in neurology, extensive research experience, and dedication to advancing care for peripheral neuropathy patients make her an exceptional addition to our leadership team. About Amanda Peltier, MD, MS Peltier is an Associate Professor at Vanderbilt University Medical […]
The Foundation for Peripheral Neuropathy (FPN) welcomes Shanna K. Patterson, MD, MS, who joined our Board of Directors effective January 1, 2025. She brings an exceptional blend of clinical expertise, academic leadership, and a long-standing commitment to improving the lives of individuals living with peripheral neuropathy. Patterson has deep roots in the neurology profession and community Patterson currently serves as the […]
Read More… from Shanna Patterson, MD, MS, joins our Board of Directors
The Foundation for Peripheral Neuropathy (FPN) is proud to announce Ronald Lissak named President of the Board of Directors, effective January 1, 2025. With a distinguished career in the medical device industry and a personal connection to peripheral neuropathy (PN), Ron brings a wealth of experience, dedication, and a clear vision to his new role. A Leader in Medical […]
We are thrilled to announce a new partnership between the Foundation for Peripheral Neuropathy (FPN) and Lilly as a 2024 Marketing and Awareness Ambassador Level Impact Partner and a 2024-25 Patient Education Webinar Series Partner. This collaboration, with Lilly’s generous support, marks a significant step forward in our mission to improve the lives of those living with peripheral neuropathy. Collaboration for Impact with Our New […]
We are thrilled to announce Regenesis as a Champion Level Impact Sponsor of the Foundation for Peripheral Neuropathy (FPN). Their generous support and commitment to our cause are crucial in advancing our mission. Regenesis is a device company dedicated to improving human welfare through the research, design, manufacture, and sale of energy-based medical products and services that alleviate pain to improve quality of life. […]
Read More… from Announcing Our Renewed Partnership with Regenesis
We are thrilled to announce CSL Behring as a Champion level Impact Sponsor of the Foundation for Peripheral Neuropathy (FPN). Their generous support and commitment to our cause are crucial in advancing our mission. CSL Behring is a global leader in biotherapeutics, dedicated to improving the quality of life for patients with rare and serious diseases. By partnering with FPN, […]
Read More… from Announcing Our Renewed Partnership with CSL Behring
We are honored to announce that on May 16, 2024, the Foundation for Peripheral Neuropathy (FPN) received an extraordinary and transformational donation of over $660,000. This unprecedented gift, given posthumously, is the largest single contribution in our organization’s history. While the donor has chosen to remain anonymous, we wish to honor and celebrate their remarkable generosity. This substantial gift will […]
Read More… from The Foundation for Peripheral Neuropathy Receives Largest Gift to Date
We are thrilled to announce a new partnership between the Foundation for Peripheral Neuropathy (FPN) and GlaxoSmithKline (GSK) as a 2024 Research Impact Partner. This collaboration, with GSK’s generous support, marks a significant step forward in our mission to improve the lives of those living with peripheral neuropathy. Expanding our reach Since our establishment in 2007, FPN has been dedicated to serving […]
Read More… from Announcing Our New Partnership with GlaxoSmithKline (GSK)
The Foundation for Peripheral Neuropathy (FPN) is proud to announce an exciting new partnership with Johnson & Johnson, one of the world’s leading healthcare companies, as an esteemed 2024 Ambassador Impact Partner. This collaboration marks a significant milestone in FPN’s mission to advance research and education for individuals affected by peripheral neuropathy (PN). Collaboration for […]